| View |
|
DR-XY34911
|
Celecoxib
|
Coxoral
|
200 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
Micro Labs Limited
|
India
|
Automatic Renewal
|
21 July 2023
|
10 September 2028
|
| View |
|
DR-XY34912
|
Celecoxib
|
Aubrex
|
200 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
17 August 2023
|
10 September 2028
|
| View |
|
DR-XY34926
|
Ispaghula (Plantago ovata seed shells)
|
Mucofalk (Orange Flavor)
|
3.25 g/5 g
|
Granules
|
Bulk Laxative
|
Losan Pharma GmbH
|
Germany
|
Initial
|
20 October 2021
|
23 July 2025
|
| View |
|
DR-XY34937
|
Sertraline (as hydrochloride)
|
Exulten
|
50 mg
|
Tablet
|
Antidepressant
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
26 October 2023
|
15 September 2028
|
| View |
|
DR-XY34970
|
Drospirenone + Ethinylestradiol
|
Yaz
|
3 mg/ 20 mcg
|
Film-Coated Tablet
|
-
|
Bayer Weimar GmbH und Co. KG
|
Germany
|
Automatic Renewal
|
04 May 2023
|
20 July 2028
|
| View |
DR-XY34973_PI_01.pdf
|
DR-XY34973
|
Gadoxetic acid, disodium
|
Primovist
|
181.43 mg/mL (0.25 mmol/mL)
|
Solution for Intravenous Injection (I.V.)
|
Paramagnetic contrast media
|
Bayer Pharma AG
|
Germany
|
-
|
10 March 2021
|
10 March 2026
|
| View |
|
DR-XY34979
|
Paracetamol + Phenylephrine Hydrochloride + Dextromethorphan Hydrobromide
|
Tusedex
|
325 mg/25 mg/10 mg
|
Capsule
|
Analgesic/ Antipyretic/Nasal Decongestant/ Antitussive
|
Lloyd Laboratories,Inc.
|
Philippines
|
Automatic Renewal
|
07 June 2023
|
30 September 2028
|
| View |
|
DR-XY34980
|
Paracetamol/ Phenylpropanolamine hydrochloride/
Chlorphenamine maleate
|
Symdex-D Forte
|
500mg/25mg/2mg
|
Tablet
|
-
|
Allied Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
26 July 2021
|
30 September 2025
|
| View |
|
DR-XY35004
|
Nimodipine
|
Nimotop
|
30 mg
|
Tablet
|
Calcium Channel Blocker
|
Bayer Pharma AG
|
Germany
|
Automatic Renewal
|
21 July 2023
|
06 October 2028
|
| View |
DR-XY3501_PI_01.pdf
|
DR-XY3501
|
Sucralfate
|
Iselpin
|
1 g
|
Tablet
|
Cytoprotector
|
Interphil Laboratories
|
Philippines
|
Renewal
|
09 March 2024
|
26 March 2029
|
| View |
|
DR-XY35019
|
Clarithromycin
|
KXD
|
125 mg/5 mL
|
Granules For Suspension
|
Antibacterials
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 July 2023
|
10 October 2028
|
| View |
|
DR-XY35024
|
Tramadol + Paracetamol
|
Dolcet
|
37.5 mg/325 mg
|
Tablet
|
Opioid Analgesic
|
Janssen Cilag SpA
|
Italy
|
Renewal
|
11 August 2023
|
13 October 2028
|
| View |
|
DR-XY35026
|
Rosuvastatin (as calcium)
|
Rovista
|
20mg
|
Film-Coated Tablet
|
-
|
Getz Pharma (Pvt.) Ltd.
|
Pakistan
|
Initial Variation]
|
16 January 2024
|
16 January 2029
|
| View |
|
DR-XY35027
|
Rosuvastatin (as calcium)
|
Rovista
|
10mg
|
Film-Coated Tablet
|
-
|
Getz Pharma (Pvt.) Ltd.
|
Pakistan
|
Initial Variation]
|
16 January 2024
|
16 January 2029
|
| View |
|
DR-XY35028
|
Rosuvastatin (as calcium)
|
Rovista
|
5mg
|
Film-Coated Tablet
|
Antihypercholesterolemia / Antidyslipidemia
|
Getz Pharma (Pvt.) Ltd.
|
Pakistan
|
Initial Variation]
|
16 January 2024
|
16 January 2029
|
| View |
|
DR-XY35033
|
Azelastine Hydrochloride
|
Azela
|
1mg/mL NASAL SPRAY
|
Nasal Spray
|
Antihistamine
|
Siu Guan Chem. Ind. Co., Ltd.
|
Taiwan
|
Renewal
|
13 September 2023
|
13 October 2028
|
| View |
|
DR-XY35042
|
Bromhexine Hydrochloride + Phenylephrine Hydrochloride + Guaifenesin
|
Flemnil
|
4 mg/2.5 mg/50 mg per 5mL
|
Syrup
|
-
|
Raptakos Brett & Co. Ltd.
|
India
|
-
|
18 February 2021
|
15 October 2025
|
| View |
|
DR-XY35058
|
Sildenafil (as citrate)
|
Neo-Up
|
100 mg
|
Film-Coated Tablet
|
Phosphodiesterase type-5 (PDE-5) Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
10 January 2019
|
20 October 2028
|
| View |
|
DR-XY35059
|
Sildenafil (as citrate)
|
Neo-Up
|
50 mg
|
Film-Coated Tablet
|
Phosphodiesterase type-5 (PDE-5) Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
30 August 2023
|
20 October 2028
|
| View |
|
DR-XY35067
|
Doxycycline (as hyclate)
|
Doxtralin
|
100 mg
|
Capsule
|
Antibacterial
|
Lloyd Laboratories,Inc.
|
Philippines
|
Automatic Renewal
|
26 July 2023
|
24 October 2028
|